Reviva Pharmaceuticals Holdings Inc —— 财务报表 (NASDAQ:RVPH) | MetaTrader

展开完整图表

新闻

Does Cobenfy Have the Potential to Become a Top Drug for BMY?

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.44%

美国股市收低；截至收盘道琼斯工业平均指数下跌0.44%

D. Boral Capital将Reviva Pharmaceuticals股票评级下调至持有

D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold

Reviva Pharmaceuticals将于3月9日实施1比20反向拆股

Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9

Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia

Chardan Capital 开始对 Reviva Pharmaceuticals 股票进行覆盖并给予买入评级

Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com

H.C. Wainwright 重申 Reviva Pharmaceuticals 为"买入"评级